Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mesenchymal stem cells (Guangzhou Bio-gene Technology)
- Development stage
- Unknown
- Lead developer
- Guangzhou Bio-gene Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Mesenchymal stem cells (MSCs) developed by Guangzhou Bio-gene Technology are an investigational cell therapy being evaluated for the treatment of refractory primary immune thrombocytopenia (ITP). MSCs are multipotent stromal cells known for their potent immunomodulatory and anti-inflammatory properties. In the context of ITP, an autoimmune disorder characterized by low platelet counts due to immune-mediated destruction and impaired production, MSCs are thought to restore immune homeostasis. They achieve this by suppressing the activation of T and B lymphocytes, promoting the expansion of regulatory T cells (Tregs), and modulating the cytokine environment to favor an anti-inflammatory state. This therapeutic approach aims to reduce platelet clearance and potentially enhance platelet production in patients who have failed standard treatments.
- Other names
- MSCsMesenchymal stem cells
Beyond the preview
Go deeper on Mesenchymal stem cells (Guangzhou Bio-gene Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mesenchymal stem cells (Guangzhou Bio-gene Technology).